ANS Flashcards
A agonist
Phenylephrine
a1 > a2
Clonidine
a2 > a1
Mixed a and B agonist
Norepinephrine
a1 = a2, B1
Epinephrine
a1=a2 b1=b2
B Agonist
Dobutamine . B1>B2»»a
Isoproterenol B1=B2»_space;»a
Terbutaline/albuterol B2»B1»»a
Dopamine Agonist
Dopamine . D1=D2»B
Fenoldopam D1»D2
Termination of Catecholamine
Reuptake,
MAO,
COMT,
Lungs
Termination of non-catecholamine
MAO Urinary Excretion (unchanged)
Sympathomimetic
Beta-phenylethylamine derivatives
Amine (NH2) side chain
Hydroxy group on 3,4 Cs of benzene ring –> catechol
Synthetic non-catecholamine
Indirect Acting:
Ephedrine, mephentermine, amphetamines
Direct Acting
phenylephrine, methoxamine
Epinephrine
Most potent a activator SQ or IV Very poor lipid soluble Onset: 1-2 min, SQ 5-10 Duration: 5-10 min
Epinephrine Indications
bronchial asthma, acute allergic reaction cardiac arrest, asystole Electromechanical dissociation V-fib Infusion to > myocardial contractility
Epinephrine Dosing
10 mcg/kg IV Bolus 2-8 mcg/kg 1-2 mcg/min IV = B2 4-5 mcg/min IV = B1 10-20 mcg/min IV = a and;B
CV Effects of Epinephrine
a1- vasoconstriction: >BP/CVP, > cardiac work (>Preload)
a2 negative feedback: contractility/ HR/ CO = >BP
B2 Peripheral vasodilation: SBP, < DBP, MAP same
Epinephrine: vasoconstriction of arterioles
minimal
cerebral vasculature
Coronary vasculature
Pulmonary vasculature
Epinephrine Eye Effects
a1 = mydriasis
a1/a2 > humoral outflow
B1 > production of humor
> IOP
Epinephrine Resp Effects
B2: dilate bronchi smooth muscle, < release of histamine
a1: < mucosal secretion/ decongestion
GI effects of Epinehrine
a2: < digestive secretions
a, B2: < peristalsis
a1: < splanchnic blood flow
GU effects of Epi
a1: < renal blood flow, contraction of urethral sphincter, facilitate ejaculation
B1: > renin release
B2: bladder relaxation (
Metabolic effects of Epi
B2: > liver glycogenolysis, > Insulin release
B3: > lipolysis
a2: (minor) < insulin release
Norepinephrine
4-16 mcg/min
Effects: vasoconstriction (@skeletal, kidney, liver, cutaneous) = met acidosis, >SBP/DBP/MAP
Baroreceptors: will < HR, < resp
Dopamine Doses
1-3 mcg/kg/min dopamine 1 receptor dominate 3-10 mcg/kg/min B1 dominate >10mcg/kg/min a stimulation dominate
PIV dangerous-infiltrate
Less vasoconstriction then NE
Dopamine effects
> contractility, renal blood flow, UO, GFR
NE release (not as useful w/ < catecholamine stores)
synergistic w/ dobutamine (CO)
inhibitory @ carotid body
IOP